The Government has announced funding of a further €58.8 million to 12 new projects under the Disruptive Technology and Innovation Fund (DTIF).
A diverse range of projects were selected, with some described by Minister for Enterprise, Trade and Employment, Simon Coveney as "potentially life-changing".
These include providing a new minimally invasive and targeted treatment for metastatic lung cancer, and using AI to detect abnormal brain activity in infants at birth.
"These disruptive projects will also ensure that Ireland's research and innovation ecosystem is well placed to capitalise on emerging growth sectors while delivering on net zero commitments, decarbonisation and digital transformation, in line with the objectives of the White Paper for Enterprise," Minister Coveney said.
The Disruptive Technologies Innovation Fund (DTIF) is a €500 million fund established under the National Development Plan (NDP) in 2018.
The Department of Enterprise, Trade and Employment manages the DTIF with administrative support from Enterprise Ireland.
The purpose of the Fund is to drive collaboration between Ireland's world-class research base and industry as well as facilitating enterprises to compete directly for funding in support of the development and adoption of these technologies.
Leo Clancy, CEO of Enterprise Ireland said projects funded under previous DTIF rounds are supporting "ground-breaking" technologies.
He said he expects the funding provided to 12 new projects under this latest investment round to have a similar impact.
"DTIF is a vital funding stream for both the Irish research community and innovative companies looking to collaborate and Enterprise Ireland is proud to play a role in its delivery," he added.
